Literature DB >> 27826805

Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.

Alyssa Kne1, Heather Zierhut2, Shari Baldinger3, Karen K Swenson4, Pamela Mink5, Patricia McCarthy Veach2, Michaela L Tsai3.   

Abstract

Family history information comprises an important tool in identifying and referring patients at risk for hereditary breast and ovarian cancer (HBOC) to cancer genetic counseling. Despite recommendations and support provided by numerous professional organizations, cancer genetic counseling services are underutilized by atrisk patients. This study aimed to: (1) determine the rate of genetic counseling utilization following a referral letter, (2) characterize factors (barriers and supports) which influenced uptake of services, and (3) identify potential strategies for increasing utilization. This study evaluated the uptake of cancer genetic counseling among 603 screening mammography patients identified as having an increased risk for HBOC based on National Comprehensive Cancer Network (NCCN) guidelines. At risk individuals and their primary care providers were mailed a referral letter recommending genetic counseling. Three focus groups (N = 24) were conducted to identify responses to receiving a letter recommending genetic counseling, barriers to seeking genetic counseling, and facilitating factors to utilizing these services. Participant responses were qualitatively analyzed using thematic and cross case analysis. Within one year, 50/603 (8 %) of the identified at-risk women completed a genetic counseling appointment. Participant-perceived barriers which influenced their decision not to seek genetic counseling included lack of relevance and utility, limited knowledge about genetic counseling, concerns about the genetic counseling process, and concerns about cost and insurance coverage. Participant-perceived facilitating factors which would support a decision to seek genetic counseling included greater awareness and education about genetic counseling services when receiving a referral, and improved follow up and guidance from their provider. Findings from this study support the need for patient and primary care provider education, and improved provider-patient communication to increase uptake of genetic counseling services.

Entities:  

Keywords:  Barriers; Cancer genetic counseling; Hereditary breast and ovarian cancer; Supports; Utilization

Mesh:

Year:  2016        PMID: 27826805     DOI: 10.1007/s10897-016-0040-0

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  46 in total

1.  A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.

Authors:  Robert Resta; Barbara Bowles Biesecker; Robin L Bennett; Sandra Blum; Susan Estabrooks Hahn; Michelle N Strecker; Janet L Williams
Journal:  J Genet Couns       Date:  2006-04       Impact factor: 2.537

2.  Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.

Authors:  Joan L Bottorff; Pamela A Ratner; Lynda G Balneaves; Chris G Richardson; Mary McCullum; Tom Hack; Karen Chalmers; Jane Buxton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-01       Impact factor: 4.254

3.  Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians.

Authors:  Tan-Min Chin; Sing-Huang Tan; Siew-Eng Lim; Philip Iau; Wei-Peng Yong; Seng-Weng Wong; Soo-Chin Lee
Journal:  Cancer Detect Prev       Date:  2005-09-23

4.  Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.

Authors:  Katrina F Trivers; Laura-Mae Baldwin; Jacqueline W Miller; Barbara Matthews; C Holly A Andrilla; Denise M Lishner; Barbara A Goff
Journal:  Cancer       Date:  2011-07-25       Impact factor: 6.860

5.  Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-02-18       Impact factor: 25.391

6.  Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.

Authors:  C Foster; D G R Evans; R Eeles; D Eccles; S Ashley; L Brooks; T Cole; J Cook; R Davidson; H Gregory; J Mackay; P J Morrison; M Watson
Journal:  Genet Test       Date:  2004

7.  Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization.

Authors:  Douglas E Levy; Judy E Garber; Alexandra E Shields
Journal:  J Gen Intern Med       Date:  2009-05-20       Impact factor: 5.128

8.  Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.

Authors:  Kathryn J Schlich-Bakker; Herman F J ten Kroode; Carla C Wárlám-Rodenhuis; Jan van den Bout; Margreet G E M Ausems
Journal:  Genet Med       Date:  2007-11       Impact factor: 8.822

9.  Patient-reported hereditary breast and ovarian cancer in a primary care practice.

Authors:  John M Quillin; Alexander H Krist; Maria Gyure; Rosalie Corona; Vivian Rodriguez; Joseph Borzelleca; Joann N Bodurtha
Journal:  J Community Genet       Date:  2013-07-20

10.  Family history-taking in community family practice: implications for genetic screening.

Authors:  L S Acheson; G L Wiesner; S J Zyzanski; M A Goodwin; K C Stange
Journal:  Genet Med       Date:  2000 May-Jun       Impact factor: 8.822

View more
  14 in total

1.  Utilization of clinical genetic counseling among childhood and young adult cancer survivors in a registry trial.

Authors:  Nassim Anderson; Arash Delavar; Danielle Novetsky Friedman; Vijai Joseph; Nidha Mubdi; Kevin C Oeffinger; Charles A Sklar; Kenneth Offit; Matthew Matasar; Nirupa Raghunathan; Zoltan Antal; David Straus; Michael Walsh; Alicia Latham; Emily S Tonorezos
Journal:  J Community Genet       Date:  2020-07-16

2.  Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening.

Authors:  Luigina Bonelli; Ivana Valle; Ivana Rebora; Paola Ricci; Lidia Biocchi; Giovanna Bruschi; Sabrina Parodi; Carla Bruzzone; Liliana Varesco
Journal:  Fam Cancer       Date:  2021-10-20       Impact factor: 2.446

3.  Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.

Authors:  Maija Reblin; Monica L Kasting; Kelli Nam; Courtney L Scherr; Jongphil Kim; Ram Thapa; Cathy D Meade; M Catherine Lee; Tuya Pal; Gwendolyn P Quinn; Susan T Vadaparampil
Journal:  Breast J       Date:  2018-11-28       Impact factor: 2.431

4.  Strategies to enhance identification of hereditary breast cancer gene carriers.

Authors:  Sonya Reid; Lucy B Spalluto; Tuya Pal
Journal:  Expert Rev Mol Diagn       Date:  2020-09-11       Impact factor: 5.225

5.  Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?

Authors:  Vida Henderson; Pam Ganschow; Catharine Wang; Kent F Hoskins
Journal:  Cancer       Date:  2021-08-23       Impact factor: 6.860

6.  Comparison of a Cancer Family History Collection and Risk Assessment Tool - ItRunsInMyFamily - with Risk Assessment by Health-Care Professionals.

Authors:  Jordon B Ritchie; Brandon M Welch; Caitlin G Allen; Lewis J Frey; Heath Morrison; Joshua D Schiffman; Alexander V Alekseyenko; Brian Dean; Chanita Hughes Halbert; Cecelia Bellcross
Journal:  Public Health Genomics       Date:  2021-12-06       Impact factor: 2.132

Review 7.  Barriers and strategies to integrate medical genetics and primary care in underserved populations: a scoping review.

Authors:  Ann F Chou; Ashten R Duncan; Gene Hallford; David M Kelley; Lori Williamson Dean
Journal:  J Community Genet       Date:  2021-02-01

8.  A qualitative study of barriers to genetic counseling and potential for mobile technology education among women with ovarian cancer.

Authors:  Rachel Isaksson Vogel; Kristin Niendorf; Heewon Lee; Sue Petzel; Hee Yun Lee; Melissa A Geller
Journal:  Hered Cancer Clin Pract       Date:  2018-07-04       Impact factor: 2.857

9.  Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.

Authors:  Soyoun Rachel Kim; Alicia Tone; Raymond H Kim; Matthew Cesari; Blaise A Clarke; Lua Eiriksson; Tae L Hart; Melyssa Aronson; Spring Holter; Alice Lytwyn; Manjula Maganti; Leslie Oldfield; Steven Gallinger; Marcus Q Bernardini; Amit M Oza; Bojana Djordjevic; Jordan Lerner-Ellis; Emily Van de Laar; Danielle Vicus; Trevor J Pugh; Aaron Pollett; Sarah E Ferguson
Journal:  Cancer       Date:  2021-05-13       Impact factor: 6.860

10.  Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors.

Authors:  Cara N Cacioppo; Brian L Egleston; Dominique Fetzer; Colleen Burke Sands; Syeda A Raza; Neeraja Reddy Malleda; Elisabeth McCarty Wood; India Rittenburg; Julianne Childs; David Cho; Martha Hosford; Tina Khair; Jamil Khatri; Lydia Komarnicky; Trina Poretta; Fahd Rahman; Satish Shah; Linda J Patrick-Miller; Susan M Domchek; Angela R Bradbury
Journal:  Cancer Med       Date:  2021-06-08       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.